May 6, 2022
1 min read

Pfizer sets up global drug development centre in India

It will also develop and support products in global markets and Pfizer’s manufacturing centres worldwide…reports Asian Lite News

Global pharma giant Pfizer, which developed the mRNA-based vaccine against Covid, on Wednesday announced setting up a global drug development centre to boost critical research and development (R&D) capabilities in India.

The 61,000 sq ft research and technology centre will be set up at the Indian Institutes of Technology (IIT) Madras Research Park in Chennai, the company said. Pfizer said it has invested more than Rs 150 crore in it.

While this centre will be a part of a network of 12 global centres set up worldwide, it is the first and only one at present being set up by Pfizer in Asia.

“We are confident that this research centre would be aligned with our larger national objective to improve the availability, affordability and access to drugs throughout the world from India by building on the convergence with digital solutions available here, and leveraging academic collaborations,” said S. Aparna, Secretary, Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilisers, during the launch.

The centre will include the development of both, active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) of differentiated products such as complex/value-added formulations, controlled-release dosage forms, device-combination products, lyophilised injections, powder-fill products, and ready-to-use formulations.

It will also develop and support products in global markets and Pfizer’s manufacturing centres worldwide.

“Pfizer’s drug development centre in the IIT Madras Research Park is a positive opportunity to establish truly one of the most advanced laboratories that Pfizer is setting up for R&D in the aforementioned disciplines anywhere in the world, in Chennai and an opportunity to showcase the potential of R&D in the country,” said S. Sridhar, Country Manager, Pfizer India, in a statement.

ALSO READ-Pfizer set to supply Paxlovid Covid pills to Africa

Previous Story

‘No Shadow Without Light’: A must-read environmental bestseller

Next Story

SC to examine if larger bench should hear sedition pleas

Latest from Business

Gold Shines Bright Amid Global Jitters

Gold and silver continued their bullish run on Monday, scaling new highs amid mounting global uncertainties, heightened geopolitical tensions, and growing expectations of a US Federal Reserve rate cut. According to the

ADNOC signs 15-year LNG deal with Indian Oil

Under the deal, LNG cargoes can be delivered to any port across India, enhancing the country’s energy security and meeting its rising energy demand. Abu Dhabi National Oil Company (ADNOC) has signed

Canada to lift counter-tariffs on US goods

Canadian Prime Minister Mark Carney has announced that Ottawa will remove its counter-tariffs on US goods covered under the Canada-US-Mexico Agreement (CUSMA), beginning 1 September. The move marks a partial easing of

PM Modi: India poised to lead next tech wave

PM Modi underscored that the country is poised to lead the next wave of digital transformation in 5G…reports Asian Lite News Prime Minister Narendra Modi on Wednesday hailed India’s progress in expanding
Go toTop

Don't Miss

Field formations of Indian armed forces get greater financial powers

The primary focus of the enhanced delegation of financial powers

Sunrisers Edge Royals in Nail-Biting Finish

The nail-biting win takes SRH to fourth place, where they